Orange S.A. (FRA:FTE1)

Blueprint Medicines Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	40,274	40,260	39,678	39,127	42,522	42,270
Revenue Growth (YoY)	0.27%	1.47%	1.41%	-7.98%	0.60%	0.08%
Cost of Revenue	25,754	24,297	24,695	23,970	26,960	25,294
Gross Profit	14,520	15,963	14,983	15,157	15,562	16,976
Selling, General & Admin	791	810	809	848	930	887
Other Operating Expenses	1,251	1,146	1,106	1,226	1,591	1,872
Operating Expenses	9,936	9,687	9,533	9,339	11,076	11,277
Operating Income	4,584	6,276	5,450	5,818	4,486	5,699
Interest Expense	-1,464	-1,468	-1,383	-1,149	-1,139	-1,273
Earnings From Equity Investments	-214	-348	-29	-2	3	-2
Currency Exchange Gain (Loss)	-15	-40	-51	-117	45	-84
Other Non Operating Income (Expenses)	361	444	245	343	295	62
EBT Excluding Unusual Items	3,252	4,864	4,232	4,893	3,690	4,402
Merger & Restructuring Charges	-203	-149	-484	-157	-345	-43
Impairment of Goodwill	-	-	-	-817	-3,702	-
Gain (Loss) on Sale of Investments	-141	-160	-129	-107	-84	-55
Gain (Loss) on Sale of Assets	-98	-279	90	233	2,507	228
Asset Writedown	-58	-62	-116	-110	-108	-87
Legal Settlements	-100	-162	-41	-50	-218	-238
Other Unusual Items	-2	-2	11	-	-	-
Pretax Income	2,650	4,050	3,563	3,885	1,740	4,207
Income Tax Expense	985	1,355	875	1,313	962	-848
Earnings From Continuing Operations	1,665	2,695	2,688	2,572	778	5,055
Earnings From Discontinued Operations	41	207	203	45	-	-
Net Income to Company	1,706	2,902	2,891	2,617	778	5,055
Minority Interest in Earnings	-578	-552	-451	-471	-545	-233
Net Income	1,128	2,350	2,440	2,146	233	4,822
Preferred Dividends & Other Adjustments	176	176	175	200	225	255
Net Income to Common	952	2,174	2,265	1,946	8	4,567
Net Income Growth	-52.74%	-3.69%	13.70%	821.03%	-95.17%	60.52%
Shares Outstanding (Basic)	2,235	2,659	2,659	2,658	2,657	2,656
Shares Outstanding (Diluted)	2,236	2,660	2,661	2,687	2,658	2,684
Shares Change (YoY)	-16.27%	-0.03%	-0.98%	1.09%	-0.97%	-0.16%
EPS (Basic)	0.43	0.82	0.85	0.73	0.00	1.72
EPS (Diluted)	0.43	0.82	0.85	0.73	0.00	1.71
EPS Growth	-48.59%	-4.00%	16.88%	24110.60%	-99.82%	66.88%
Free Cash Flow	3,151	3,485	4,225	2,458	2,487	4,151
Free Cash Flow Per Share	1.41	1.31	1.59	0.92	0.94	1.55
Dividend Per Share	0.750	0.750	0.720	0.700	0.700	0.700
Dividend Growth	4.17%	4.17%	2.86%	-	-	40.00%
Gross Margin	36.05%	39.65%	37.76%	38.74%	36.60%	40.16%
Operating Margin	11.38%	15.59%	13.74%	14.87%	10.55%	13.48%
Profit Margin	2.36%	5.40%	5.71%	4.97%	0.02%	10.80%
Free Cash Flow Margin	7.82%	8.66%	10.65%	6.28%	5.85%	9.82%
EBITDA	11,212	12,955	12,891	12,960	11,644	12,888
EBITDA Margin	27.84%	32.18%	32.49%	33.12%	27.38%	30.49%
D&A For EBITDA	6,628	6,679	7,441	7,142	7,158	7,189
EBIT	4,584	6,276	5,450	5,818	4,486	5,699
EBIT Margin	11.38%	15.59%	13.74%	14.87%	10.55%	13.48%
Effective Tax Rate	37.17%	33.46%	24.56%	33.80%	55.29%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.